Drug development for treatment of glutamate dehydrogenase hyperinsulinism
Awardee: Li Changhong
Institution: Children's Hospital of Philadelphia
Award Amount: $82,000
Funding Period: January 1, 2017 - December 31, 2017
Previous
Previous
Role of mitochondria and ROS in etiology of SRS
Next
Next